Eli & Co Lilly, 10% Owner at Zymeworks Inc. (ZYME), sold 41,018 shares at $14.32 ($598K) on 2018-09-13, disclosed to the SEC on 2018-09-14.
Open-market sale of $598k ZYME by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.83 | 10,059 | $149K | 25.0% |
| 2 | $14.83 | 10,059 | $149K | 25.0% |
| 3 | $14.32 | 20,900 | $299K | 50.1% |
| Total | $14.57 avg | 41,018 | $598K | 100% |
| Filing → |
| ZYME | SELL | 2018-09-26 | $33K | — | Filing → |
| ZYME | SELL | 2018-09-20 | $200K | — | Filing → |
| ZYME | SELL | 2018-09-18 | $463K | — | Filing → |